These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 22811549)

  • 21. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
    J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular dysfunction with pulmonary hypertension: Part 1: epidemiology, pathophysiology, and definitions.
    Georgiopoulou VV; Kalogeropoulos AP; Borlaug BA; Gheorghiade M; Butler J
    Circ Heart Fail; 2013 Mar; 6(2):344-54. PubMed ID: 23513049
    [No Abstract]   [Full Text] [Related]  

  • 24. Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction.
    Goldberg LR; Jessup M
    Circulation; 2006 Jun; 113(24):2851-60. PubMed ID: 16785351
    [No Abstract]   [Full Text] [Related]  

  • 25. How far do we want to go in the treatment of obstruction in Hypertrophic Cardiomyopathy?
    Pastor A; Petrillo F; Navarro M; González-Carrillo J; de la Morena G
    Int J Cardiol; 2015 Sep; 195():95-7. PubMed ID: 26025866
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiac amyloidosis.
    Kingman A; Pereira NL
    J S C Med Assoc; 2001 May; 97(5):201-6. PubMed ID: 11381776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histopathologic correlates of myocardial improvement in patients supported by a left ventricular assist device.
    Segura AM; Frazier OH; Demirozu Z; Buja LM
    Cardiovasc Pathol; 2011; 20(3):139-45. PubMed ID: 20185339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Heart failure in hypertrophic cardiomyopathy].
    Arq Bras Cardiol; 1992 Aug; 59(2):135-9. PubMed ID: 1341159
    [No Abstract]   [Full Text] [Related]  

  • 29. [Relationships between distribution of disorganized cardiac muscle cells and disease state in hypertrophic cardiomyopathy].
    Morimoto S; Sekiguchi M; Nishikawa T
    J Cardiol Suppl; 1987; 16():9-24. PubMed ID: 3509686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI of hypertrophic cardiomyopathy: part I, MRI appearances.
    Hansen MW; Merchant N
    AJR Am J Roentgenol; 2007 Dec; 189(6):1335-43. PubMed ID: 18029869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remodeling in systolic heart failure: therapeutic implications.
    Chatterjee K
    Indian Heart J; 2004; 56(2):99-109. PubMed ID: 15377130
    [No Abstract]   [Full Text] [Related]  

  • 32. A few more pieces in the puzzle of non-compaction cardiomyopathy.
    Willemsen HM; van den Berg MP
    Eur J Heart Fail; 2011 Feb; 13(2):127-9. PubMed ID: 21262927
    [No Abstract]   [Full Text] [Related]  

  • 33. [Influence of left ventricular dilation on clinical profile of patients with hypertropic cardiomyopathy].
    Wu D
    Hokkaido Igaku Zasshi; 2004 Mar; 79(2):147-53. PubMed ID: 15101190
    [No Abstract]   [Full Text] [Related]  

  • 34. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
    Amigoni M; Meris A; Thune JJ; Mangalat D; Skali H; Bourgoun M; Warnica JW; Barvik S; Arnold JM; Velazquez EJ; Van de Werf F; Ghali J; McMurray JJ; Køber L; Pfeffer MA; Solomon SD
    Eur Heart J; 2007 Feb; 28(3):326-33. PubMed ID: 17251259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Heart failure due to idiopathic cardiomyopathy and its management].
    Inoo T
    Nihon Rinsho; 1972 Oct; 30(10):2091-7. PubMed ID: 4569484
    [No Abstract]   [Full Text] [Related]  

  • 36. Imaging phenotype versus genotype in hypertrophic cardiomyopathy.
    Desai MY; Ommen SR; McKenna WJ; Lever HM; Elliott PM
    Circ Cardiovasc Imaging; 2011 Mar; 4(2):156-68. PubMed ID: 21406662
    [No Abstract]   [Full Text] [Related]  

  • 37. Pressure overload.
    Frohlich ED; Susic D
    Heart Fail Clin; 2012 Jan; 8(1):21-32. PubMed ID: 22108724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology of heart failure following myocardial infarction.
    Struthers AD
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii14-6; discussion ii31, ii43-8. PubMed ID: 15831601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-terminal pro-brain natriuretic peptide from fresh urine for the biochemical detection of heart failure and left ventricular dysfunction.
    Jungbauer CG; Buchner S; Birner C; Resch M; Heinicke N; Debl K; Buesing M; Biermeier D; Schmitz G; Riegger G; Luchner A
    Eur J Heart Fail; 2010 Apr; 12(4):331-7. PubMed ID: 20185430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linkage between mechanical and electrical alternans in patients with chronic heart failure.
    Kodama M; Kato K; Hirono S; Okura Y; Hanawa H; Yoshida T; Hayashi M; Tachikawa H; Kashimura T; Watanabe K; Aizawa Y
    J Cardiovasc Electrophysiol; 2004 Mar; 15(3):295-9. PubMed ID: 15030419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.